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Microbiology

The effect of cell wall inhibitors on phospholipid canposition and
metabolism in Bacillus stearothermophilus. (75 pp. )
Director; Dr. George Card
The effect of various inhibitors of peptidoglycan synthesis on the
ccraposition and patterns of metabolism of membrane phospholipid
was studied in vtole cells and isolated membrane preparations.
Bacitracin, vancomycin, and ristocetin, all of which block steps
of cell wall synthesis involving the bactoprenol lipid carrier
cycle, caused a marked elevation of the cardiolipin concentration
with a corresponding decrease in phosphatidylglycerol- Pulse
labeling studies revealed that phospholipid turnover was un
affected, however, an as yet unidentified lipid (unknown A) was
seen to accunulate. Bactoprenol intermediates were extracted from
washed membranes, and on comparison it was found that the unknown
A corresponded to the second of three major bands. Further
characterisation of this unknown lipid by mild acid hydrolysis (in
order to remove the end group from bactoprenol) yielded a product
that was soluble in chloroform and chromatographed on SG 81 papers
apparently as a phospholipid. Subsequent déacylation of this acid
hydrolysis product revealed a glycerol phosphate ester, vAiose
chromatographic properties were similar to the unknown described
by Card (Card, G.L.,J. Bacteriol. 114; 1125-1137, 1973.) Cardio
lipin accumulation in vancomycin treated cells was shown to occur
after a delayed response. Time dependent studies of the bacto
prenol intermediates isolated from membranes treated with vanco
mycin showed that as the unknown A decreased with respect to time,
there was an apparent increase in bactoprenol-PP. This also
corresponded with the increase in cardiolipin content. These
results were interpreted as evidence for the coupling of phospho
lipid metabolism with cell wall synthesis.
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Reality has no obligation to be interesting; only our
hypotheses about it...
Jorge Luis Borges ” Death and the Compass "

Vlll

INTRODUCTION
The concept of the lipid bilayer as the principal mode of packing
for lipids in biological membranes is new 50 years old, and in recent
years this has been develc^sed into the generally accepted Fluid Mosaic
Model (110).

There is now carpelling evidence that membranes are vect-

torial structures; that is, there is an asyirmetric distribution of not
only their protein constituents but also their phospholipid components
(4, 8, '9, 82, 100, 101).
asymmetry is unknown.

The physiological relevance of phospholipid

Asymmetric lipid canpositiais could possibly reg

ulate differential membrane fluidity, or act as bilayer couples; here,
they would differentially respond to perturbation (8).

One clearly

established fact is that there is no universal preference with regards to
the bilayer distribution of a single phospholipid species (8, 82, 100).
Any model dealing with membrane bc^xDgraphy must allow for the mem
brane's remarkable ability to maintain it's integrity.

By changing it's

phosjdTolipid composition, an organism has the means to withstand the
pleiotrophic changes within it's environment.

A ready interpretation in

certain cases could be the maintenance of a suitable anionic surface
charge.

This can be readily achieved by an alteration of the distribu

tion of the acidic and basic phospholipids within the membrane.

The

question of how an organian can adapt so readily remsdns unresolved.
Phospholipids have an extremely high rate of lateral diffusion (62),
vhereas trans-bilayer interchange (flip-flop), vhich is thermodynamically
unfavorable, proceeds very slowly (8, 89). Rothman and Kennedy (99) vthen
studying Bacillus megaterium, determined that the principal phospholipid,
phosphatidylethanolamine (PE), is synthesised in an inteimal pool with
subsequent rapid translocation to the extra-cytoplasmic side of the manr
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brane.

They suggest that this rapid translocation

on the order of

three minutes - is due to catalysis by a specific membrane protein.
Membranes are ocmposed primarily of phospholipid and protein.

Phos

pholipids are an#iipathic molecules that account for 20-40% of the dry
weight of bacterial membranes; the remainder representing the protein
content. The hydrophylic and hydrophobic ends arise due to the unique
structure of phospholipids. All phospholipids contain a glycerol back
bone, to vhich fatty acids are usually esterified in the 1 and 2 posi
tions.

The polar head group is joined by a phosphodiester linkage to

the 3 position of this diglyceride molecule.

The distribution of the

polar head groups determines the ccKçosition of the membrane.
each individual phospholipid spaecies can change within itself.
achieved by changing it's fatty acids.

In reality,
This is

Changes resulting from this type

of molecular rearrangement tend to ciffect membrane fluidity (25).

The

study of the biosynthesis of the individual phospholipid species, as
determined ky the polar head group, has come under considerable attention
in procaryotic organians during the past two decades, and it is this
aspect that is the primary concern of this present study.
Phospholipid metabolian as determined for Escherichia coli.
The vast majority of this reseach has dealt with the Gram negative
bacterium Escherichia coli. The phospholipid composition of E.coli
wild-type cells is PE, phosphatidylglycerol (PG), and cardiolipin (CL),
in the approximate ratios 70:20:10 respjectively.

Kennedy and his cx>-

workers (89) have been able to elucidate the biosynthetic p>athway from
either glycerol or dihydroxyacetme to each of the individual phospho
lipid species.

The scheme paresented in Fig. 1 has been verified by
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three different experimental approaches.
1.

These are:

Classical deioistration of enzymes in crude extracts capable
of catalysing these reactions;

2.

Radioactive labeling to demonstrate the existance and turnover
of such intermediates;

3.

The isolation and lipid ccniposition of mutants defective in
particular enzymes in Fig. 1.

Beginning with the acylaticxi of sn-glycerol-3-P, all of the reac
tions occur on the cytoplasmic membrane (6/ 127).

Phosphatidic acid (PA)

formed frcm this initial acylation is next converted to a liponucleotide,
CDP-diglyceride, by it's reacticxi with CTP.
at the biosynthetic branchpoint.

CDP-diglyceride is located

Frcm here, phosphatidyl transferase

reactions donate the phosphatidyl moiety to either the hydroxyl group
of L-serine or to the hydroxyl group at the 1 position of sn-glycerol-3-P
to form phosphatidylserine (PS) and phosphatidylglycerolphosphate (PGP)
respectively.

PS is rapidly decarboxylated to form PE:

phorylated to PG.

PGP is dephos-

PG however, is further metabolised by a condensation

reaction to form CL.

This latter reaction requires no metabolic energy.

It has long since been recognised that PG is a rapidly metabolising
molecule with ^>praxiinately 1/3 turning over in a single generation in
E.coli (103).
All of the pressed enzymes in Fig. 1 have been at least partially
purified and characterised to some extent.

The lone exception is cardio

lipin synthetase vhich we have found to be resistant to extraction by the
use of detergents (unpublished chservation). The oatiroi pathway pro
ceeds with the synthesis of PA.

Membrane bound acyltransferases ester-
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Fig.l. The pathway of phospholipid metabolian as determined
for Escherichia coli (89).
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ify positions 1 and 2 of sn-glycerol~3-P. Kito*s group (55, 56) has
found that these reactions are activated by PG.

The acyltransferases

appear to be the key regulatory enzymes in response to temperature
fluctuations (25).

Studies with a glycerol auxotroph under glycerol

starvation, have revealed that the synthesis of the phosgholipids and
fatty acids are co-ordinately controlled.

During glycerol depletion,

free fatty acid accumulates in the cytoplasm of the mutant (76).

CDP-

diglyceride synthetase is the enzyme that converts PA into the liponucleotide.

This enzyme, unlike others in the pathway, appears to have

a specific requirement for an unsaturated fatty acid esterified to
position 2 (89).

Recently, Ganong and Raetz (37) have isolated a con

ditionally lethal CDP-diglyceride synthetcise mutant in which there is a
sharp elevation in PA content, with a corresponding decrease in PE and
PG.

The authors claim that the results "constitute definitive physio

logical proof that CDP-diglyceride is an obligatory precursor for over
90% of PE and PG in E.coli."
From CDP-diglyceride we find two different enzymes, phosphatidylserine synthetase (PSS) and g^sphatidylglycerolphosphate synthetase
(PGPS), that ostensibly catalyse similar reactions; the transfer of the
phosgjiatidyl grouç> from CDP-diglyceride to an alcohol.
In eucaryotic systems, the synthesis of PE involves a head group
exchange reaction of L-serine and PE, followed by irreversible decarbox
ylation (12, 27).
to occur.

However, in procaryotes, no such mechanism is known

Also, PSS derived frcm bacteria could well be the one excep

tion to the general observation that all the enzymes involved in the
latter stages of ftosf^lipid biosynthesis are membrane bound.

In vitro
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ribosaroal aussociation has been documented on nimerous occasions (30, 58,
92).

Dowhan's groL^ (67) suggests that riboscmal associaticxi does occur

in vitro, however they found that PSS is easily dissociated frcm this
ccmplex by lipid substrates and they argue that this would indicate that
the enzyme w u l d not be closely associated with ribosones during actual
catalysis within close proximetry of the membrane.

When studying the

kinetic parameters of the enzyme, Ishinaga (54) also noted the effect
of various phospholipids.

He found that CL and PE activated the enzyme,

in contrast to PG*s inhibitory effect.

Phospholipid compositions of

E.ooli mutants for the PSS gene have shown a decrease in PE with a con
comitant rise in CL when compared to wild-type (45, 78> 79).

Raetz (91)

has also shown that this rise in CL occurs in both the inner and outer
manbranes of the PSS mutant.

It is interesting to note that the PE con

tent in any of the above mutants never falls below 25%.
Homogeneous PSS not only transfers the phosphatidyl group from CDPdiglyceride to L-serine, but also exchanges free CMP with the CMP moiety
of CDP-diglyceride, and L-serine with PS (64, 93).

These exchange reac

tions suggest the possibility that there may well be a ping-pong type of
reaction with the formation of an intermediary phosphatidyl complex (18,
93).

values show that PSS has a very low affinity for L-serine (93).

Utilising a mixed micellar system of Triton X-100 and CDP-diglyceride,
it was found that increasing the concentration of the detergent maximally
stimulated the the PSS activity.

This is consistent with "substrate

dilution kinetics” in vAich an equilibrium ordered binding of the enzyme
to a surface occurs prior to catalysis (18).

Consequently, the stability

of the phos#iatidy1-enzyme ccnplex may be important in controlling the
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ratio of the zwitterionic to acidic phospholipids if in fact PSS is only
membrane boiind during catalysis.
The final step in converting CDP-diglyceride to PE occurs by a
rapid decarboxylation of PS.

Treatment of wild-type cells with hydrox-

ylamine (an inhibitor of the decarboxylase enzyme) results in the accum
ulation of large amounts of PS.

This shows that in E.ooli decarboxyla

tion represents the major biosynthetic route for the formation of PE
in vivo.
The synthesis of PGP represents the first committed step towards
the formation of PG and CL.

PGPS catalyses the estérification of the

1-hydroxyl group of sn-glycerol-3-P by the transfer of the gdiosphatidyl
moiety from CDP-diglyceride (21).

Consequently, the non-acylated

glycerol of PGP is bound to the phosphatidyl groi:ç5 by a sn-glycerol-1phosphodiester linkage.

The occuranoe of this particular enantiomeric

form of a glycerol phosphate bond is exceedingly rare (sn-glycerol-3-P
being by far the most cannon in nature). PGPS is able to catalyse the
reverse reaction.

However, due to the highly irreversible nature of the

dephosphorylation step that forms PG, the reaction is pulled in the for
ward directicm (49).

The homogeneous enzyme is specific for sn-glycerol-

3-P but it's mode of action appears to differ from that of PSS.

PGPS is

unable to catalyse the exchange reactions between CMP and CDP-diglyceride,
and sn-glycerol-3-P with PGP.

Reversal of the reaction occurs by incu

bating PGP with CMP (21, 49).
PGP has never been isolated from wild-type cells due to the rapid
déphosphorylation ty phosphatidylglycerolphosphate phosphatase (22).
The phosphatase has a relatively high affinity for PGP and p>artially
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purified fractions do not hydrolyse sn-glycerol-3-P at any significant
rate (22).
Available evidence suggests that CL is undoubtedly fomed by the
stoichiometric condensation of two PG molecules to form CL and free
glycerol as shown fcy the following equation:
2

P G ------ CL

+

glycerol.

The reaction requires no metabolic energy, and is supported by in vivo
evidence for the release of free glycerol from specifically labeled PG
molecules (3, 17, 41, 50, 70).

This reaction was further substantiated

by in vitro CL synthesis using a particulate enzyme preparation from
Microooccus lysodeikticus (28).

Characterisation of an E.coli mutant

deficient in the enzyme cardiolipin synthetase resulted in 15 fold less
CL and a 5 fold reduction in PG turnover (86).

Definitive evidence for

the above reaction came from two independent studies.

Utilising

Staphylococcus aureus. Short and White (106) showed that the fatty acids
and the phosphorus groiç>s from two PG molecules could be quantitatively
recovered in CL.

Likewise, Hirschberg and Kennedy (50) dononstrated
0*5
3
that when PG is doubly labeled with "^^P and H in the non-acylated
glycerol of PG, that the ratio of
greater than in PG.

recovered in CL was two times

This would be ocxipatible with the above equation.

Both PG and CL are further metabolised in E.coli to a soluble
extra-cytoplaanic product.

Membrane-derived-oligosaccharide (MDO) con

sists of sn-glycerol-l-P moieties from both PG and CL joined to carbon
6 of glucose residues v ^ c h are preset in a glucose polymer (123).

The

formation of MDO and CL accounts for 75% of PG turnover in E.ooli (89).
The presence of a diglyceride kinase, vAiich recycles sn-1,2-diglyceride
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back to PA within the membrane, helps further to support the idea that
MDO is derived frcm PG and CL (53, 95, 104).

A double mutant, defective

in both the kinase and MDO formation, caused a striking accumulation of
diglyceride within the membrane (96).

The presence of the kinase is

interesting because it is well established (89) that acylation of snglycerol-3-P is themajor de novo route of PA synthesis in vivo. The
availability of ATP

on the inside

location for the kinase (96).

of the membrane suggests

a cytoplasmic

If this were the case then it would

necessitate the translocation of MDO across the membrane. An interest
ing property of the

enzyme is the

strong effect exerted by

CL? both

stimulatory and in the stabilisation of the enzyme itself (104).
Regulation of phospholipid synthesis.
Clarification of our kncwledge as to the co-ordination of membrane
lipid, membrane protein, and macrcmolecular synthesis in. growing cells
would be greatly enhanced by the elucidation of the controls of phospho
lipid metabolian. Early studies of phospholipid mutants demonstrated
that genetic manipulation ves possible (47).

With the advent of Raetz's

selection procedure (87) for mutants defective in phospholipid metabolism
we have seen a great accumulation of genetic information (88).

As the

greatest expense of energy within phospholipid biosynthesis is due to
the synthesis of the fatty acids, one would therefore expect a certain
degree of control to be exerted upon fatty acid availability.

Indeed,

there avgears to be a tight coupling of phosfbolipid and fatty acid
syntheses in bacteria (76).

Additional regulation could occur at areas

in the metabolic pathway where ocmnon intermediates such as PA or CDPdiglyceride are formed.

As yet, the control of CDP-diglyceride synthe-
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sis is ill defined.

However, several mutants have been isolated for

E.ooli that have defective genes for PSS and PGPS (36, 78, 80, 81, 88,
94, 113).

An important fact that appears to emerge frcm the above stud

ies is that "the degree of cdteration of the phospholipid composition
brought about by an increase in enzyme concentration is not in the order
that would be expected if fluctuations in enzyme levels in vivo were an
important regulatory raechanian in phospholipid metabolism (81)".
should be noted that drastic results do occur
tration of the phospholipid enzymes.

It

decreasing the concen

Control vould then appear to be

mediated either by modulating the enzymatic activity or by controlling
the availability of necessary substrates.

Studies with a trans-acting

regulatory mutant of E.coli for the over production of PS revealed a
regulatory locus distinct frcm the structural gene that it controlled
(113).

A similar method of control was also recognized with mutants

defective in the gene coding for diglyceride kinase (90).

Sparrow and

Raetz (113) proposed that the control of PSS production is by "setpoint" regulation.

This is neither classical induction nor repression.

Here the gene product is maintained at all times at a certain level by
the action of a regulator.
Phospholipid metabolian in Gram positive organisms.
Vfe find that there are many striking similarities with regard to
phospholipid metabolism in Gram positive organisms as those found in
E.ooli. Early on it was recognised in both Bacilli and S.aureus that all
the enzymes that are needed for the biosynthesis of PE, PG, and CL are
paresent (73, 83, 106) and that the biosynthesis of each phospjiolipid
species proceeds via the CDP-diglyceride intermediate (83).

Character
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isation of PSS (31) has demonstrated that CDP-diglyceride can act as a
substrate for PS synthesis, and that the enzyme behaves in a similar
fashion as that that was determined for E.coli's PGP. In vitro levels of
PS decarboxylase were also reported.

Comparable results have also been

demonstrated for several other Gram positive organisms (19, 24, 63).
The glycerophosphatide sequence had been elegantly demonstrated by Short
and White (106).
Phospholipid turnover in Gram positive bacteria also appears to
bear sane similarity to that found in E.ooli. Although MDO has not been
found in Gram positives, the turnover of PG shows sane resemblance in
that the glycerophosphate groups of lipoteichoic acid appear to be de
rived from this molecule (17, 32, 33, 61, 74).
Nevertheless, several pieces of evidence have surfaced (based prim
arily from in vivo labeling studies) that suggest that an alternative
pathway may exist in conjunction with the classic Kennedy scheme.

Lang

ley (63) has reported that PE was much more slowly labeled than the
corresponding uptake

PG.

He found that at early times in the pulse,

PG sequestered 60 times more label than did PE (the letter's rate of
labeling was carparable to that demonstrated by CL). îfe also found an
elevated rate of PG turnover.

Further pulse labeling studies with B.meg

aterium (65, 66) showed there to be two distinct metabolic pools of PG.
The use of trition shewed that the label was recovered in diglyceride
on utilising a short pulse, and that rapid turnover of the non-acylated
glycerol of PG occurred with the liberation of the label in free glycerol.
To account for this, Lanbardi proposed the possibility of two intermedi
ary complexes that would involve PG and two different acceptors to
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provide:
1.

Glycerophosphoryl groups for lipoteichoic acid with the release
of diglyceride:
PG

2.

+ X ---- > glycerophosphoryl-X

+

diglceride

Phos#mtidyl grovqps for PE synthesis with the liberation of
free glycerol:
PG

+ Y ---- > phosphatidyl-Y

+

glycerol

Similar pulse chase studies with Bacillus stearothermophilus also
revealed biphasic patterns of turnover for both PG and CL.

These results

vould suggest the existance of twD pools for each lipid; one metabolically
active and one that was stable (17).

Frcm the same study it was also

shewn that turnover of CL and the phosphatidyl grou^ of PG caused the
label to appear in lipoteichoic acid.

To account for this Card further

modified Lombardi's model in order to include CL synthesis:
PG

+

Y ---- > phosphatidyl-Y +

phosphatidyl-Y

+

PG

> CL

glycerol

+

Y

The glycerol so released could then be recovered in lipoteichoic acid
with a recycling of the initial acceptor.

It vas interest with regard

to this proposed intermediary ccmplex that pronpted the present study.
Phospholipid metabolism in relation to other cellular metabolic processes
The regulation of macrcmolecular synthesis has ccme under a great
deal of scrutiny during the past 20 years (.20, 26, 39, 43, 69, 73, 77).
In all these studies it was clearly understood that regulatory mechan
isms must couple membrane metabolism with other macrcmolecular processes
in order that balanced growth can be achieved.

The molecular evidence

in support of this conclusion is particularily scant.

With the utilis

ation of synchronous cultures, several authors reported a transient
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increase in phospholipid synthesis immediately prior to cell division
(.26, 43, 69).

It has also been deteimined that phospholipid synthesis

is coupled to DMA, RNA, and protein syntheses (20, 39, 40, 77).

Studies

with various systems have shown that the synthesis of membrane-associated
protein is dependent upon phospholipid metabolism proceeding at a normal
rate (20, 40, 77).

The initial observation by Card that bacitracin (an

inhibitor to cell wall biosynthesis) caused an increase in the CL content
of exponentially growing cells, led us to believe that a possible direct
correlation may exist between phospholipid metabolism and cell wall bio
synthesis in B .stearothermophilus. Also, scattered references within
the literature have often alluded to a correlation between changes in
ftospholipid composition accompanying antibiotic resistance by a micro
organism (2, 10, 29, 52, 122). This is especially interesting vdien the
primary inhibitory mode of the antibiotic is directed at some target
other than the cytoplaanic membrane.

It appears that Gram positive

organisms are more prone to this phencmencm than their Gram negative
counterparts (.10, 29, 52).
Bacterial cell wall biosynthesis.
Bacterial cell wall biosynthesis and the study of antibiotic action
are synonymous (35).

From Card's initial observation with bacitracin,

it appeared to us that attention should be focused primarily upon inhib
itors of cell wall biosynthesis, with a special emphasis with regard to
the inhibitors of the bactoprenol lipid carrier cycle.

The pioneering

work frcm Strcminger's laboratory (107) revealed the nature of this
unique procaryotic carrier system, and this work is sunmarised in Fig. 2.
Their work unequivocably demonstrated that the antimicrobial effect
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UMP

UDP-MurlS^c-pentapeptide

P-lipid

MurNAc(pentapeptide)-PP-lipid

UDP
Pi
GlcNAc-MurNAc (-pentapeptide) -PP-lipid
Glycine + ATP
Bacitracin
ADP + Pi

\
PP-lrpid

GlcNAc-MurNAc(- hexapeptide)-PP-lipid
Vancomycin,Ristocetin

GlcNAc-MurNAc (rthexapeptide) -Acceptor

Fig. 2.

Acceptor

Reaction cycle of peptidoglycan synthesis in Micrococcus
lysodeikticus.(107)

IS
of bacitracin, a peptide antibiotic, to be due to the prevention of a
crucial déphosphorylation step that is integral to cell wall synthesis.
This occurred due to the formation of a oonplex between bacitracin, a
divalent cation, and bactoprenol-PP (107, 116, 117, 118, 119).
The first step in the cycle involves a phospho-N-Acetyl-Muramylpentapeptide translocase (46).
bound enzymes.

This is the first of several membrane

The reaction involves the transfer of N-Acetyl-Muramyl-

pentapeptide fran a soluble nucleotide diphosphate precursor to the
mono-phosçhorylated lipid carrier molecule to form the bactoprenol-PPN-Acetyl-Murarayl-pentapeptide intermediate (121).

Fran here, a second

sugar residue is added, also utilising a nucleotide diphosphate deriv
ative, and the nascent cell wall ocnçonent is coipleted by the addition
of the cross-linking amino acids (35).

It was determined that several

of these enzymes involved in this initial series of events had carplex
lipid requirenents (115, 121).

The final translocation step of the

ocmpleted disaccharide-pentapeptide moiety to an acceptor on the existing
cell wall was determined by utilising the inhibitory action of the two
aglycone antibiotics vanconycin and ristocetin (71, 75, 84, 85, 98).
Due to their interaction with acyl-p^tides that terminate with the
sequence D-Ala-D-Ala, Wiich are the final two amino acids in the crosslinking peptide (84), these antibiotics prevented the polymerisation of
the cell wall resulting in the accumulation of the bactoprenol-PPdisaccharide-pentapeptide intermediate (119).

Fran here, the bacitracin

sensitive step regenerates the initial bactoprenol-P acceptor due to the
action of the enzyme bactoprenolpyrophosphate phosphatase and the cycle
is complete (42).
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When assaying particulate enzyme preparations obtained fron S.aureus
(48) / it was found that ATP had a marked stimulatory effect on peptidoglycan synthesis.
prenol in S, aureus

It was subsequently determined that 90% of the bactoexisted in the alcohol form (47).

This and other

data (38, 47, 48, 102, 129) have made the pressed, that a possible reg
ulatory mechanism may be occuring by the combined action of two enzymes,
a phosphokinase and a phos^iatase, that mediate bactoprenol-P avail
ability appear most favorable.

An unusual property of the phosphatase

is that it has an optimal pH of 5.

This is in contrast to the other

enzymes in the cycle that operate around neutrality.

Consequently, it

is conceivable that pH gradierits across the monbrane are thereby a means
for the cell to regulate peptidoglycan synthesis.
Further inhibitory action ascribed to bacitracin, vancomycin, and
ristocetin.
In addition to these primary sites of action for the three anti
biotics mentioned, numerous reports have appeared as to possible second
ary effects that may also be attributable to than.

For example, baci

tracin has been shown to effect phospholipid metabolism in several
microorganians by decreasing the ability to incorporate (^^C)-glycerol
into the lipid fraction of Halobacterium cutirubrum (5) ; the excretion
of cellular lipids from a number of Gram positive organisms into the
medium (51) ; or in the case of S.aureus, to cause an increase in CL con
tent with a proportional decrease in PG (59).

Consistent with bacitra

cin's inhibitory mode in procaryotes, the peptide has been a powerful
tool in the study of glycolipid metabolism in eucaryotes.

Studies

utilising yeast membranes showed that bacitracin inhibited the transfer
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of N-Acetyl-gl\jc30samine from UDP-N^AcetylH31ucosamine to the isoprenoid
carrier dolichyl-P; utilising porcine aorta microscmes, bacitracin
afpeared to bind to the dolichyl-P itself (114) ; rat liver microscmes ^
showed bacitracin inhibition to be directed at the formation of dolichyl-P
frcm endogenous precursor (.60).
cl I

I

In fact, bacitracin may well inhibit

processes that involve polyisoprenoid intermediates as postulated

by Stone and Stroninger (118).
Early reports of the inhibitory effects of vancomycin and ristocetin
often alluded to possible secondary interacticn with the cytoplasmic
membrane (44, 57, 98, 105, 132).

Experiments designed to locate the

site of action of the two antibiotics revealed that adsorption to the
manbrane occured coincidently with binding to the cell wall (111). An
iodinated vancomycin preparation showed that the affinity for the man
brane was greater in vbole cell cultures than for isolated protoplasts
(85).

Labeling studies with ^^P and (^^C)-glycerol in Gram positive

bacteria (57, 132) revealed that there was a marked decrease in the
uptake into the lipid fraction on incubation with vancomycin.

Vanco

mycin also appears to have a selective effect on the synthesis of polyglycero^ and polyribitolphosphate (13, 14).

Using large concentrations

of vancomycin (but not with ristocetin) caused a 60% decrease in the
synthesis of teichoic acid.

Ccaiseguently, the use of inhibitors to cell

wall synthesis in persuing gainful information with regard to the study
of phospholipid metabolism appears to already have some precedence
within the literature.
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The proposed objectives of this study.
The objective of this study was to investigate the perturbation
of phospholipid raetabolian caused by bacitracin, and determine v^ether
in fact that cell wall synthesis and phospholipid metabolism are
intimately linked.
1.

The specific aims were;

Identification of the lipid that accumulates on bacitracin
treatment;

2.

Quantification of the changes in lipid composition induced by
the antibiotic;

3.

An analysis of the changes in phospholipid synthesis and sub
sequent turnover that are induced by bacitracin;

4.

The determination of the effect of other inhibitors to cell
wall synthesis on the phospholipid composition and metabolisn;

5.

The isolation of bacitracin resistant mutants and an analysis
of their phospholipid composition and metabolism.

MATERIALS AND METHODS

Grcwth conditions.
Bacillus stearothennophilus NCA 2184 was grown in a ccirplex medium
(TYE) consisting of 2% Trypticase (BEL Microbiology Systems) and 1%
yeast extract (Difco Laboratories). The cells were grown at 59 C in a
shaking water bath.

The larger culture volumes required for the isolation

of washed membranes necessitated the use of a gyratory incubator shaker
at the indicated temperature.

Growth was monitored by the measurement

of optical density at 600 nra in a Colenan Junior II spectrophotcmeter.
Mutant isolation.
B. stearotherroophilus 2184 was mutagenised by N-methy1-N '-nitro-Nnitrosoguanidine by a slight modification of the procedure as outlined
by Miller (72).

At an optical density of 0.3, nitrosoguanidine (5(^/ml)

was added to 50 ml of an exponentially growing culture and incubation
was continued for a further 30 min at 59 C.

The cells were then harvest

ed on ice and washed With 20 ml of TÏE medium.

The pellet from this

washing step was diluted 1:10 and resuspended in 50 ml of prewarmed medium
and further incubated until an optical density of 0.4 was reached.

Por

tions of the culture (0.1 ml) were pipetted onto bacitracin selection
plates consisting of Trypticaise Soy Agar (BBL Microbiology Systems) with
varying concentrations of bacitracin.

Two individual colonies were picked

fran the plates containing 10y^4g/ml of bacitracin. Growth in liquid cul
ture was in a medium that consisted of the ccnplex medium previously des
cribed to vhich was added bacitracin {10ju^q/ml) and 0.5% glucose.
mutants were lyophilised and stored at -15 C.
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Lipid analysis.
The distribution of

into the various lipid fractions was obtained

by growing the cells in the TYE medium containing 2^Ci of

per ml.

Relative specific activities (in counts per min per nmol of phosphate)
for each phospholipid were determined.
Cells were either continuously labeled (for approximately five cell
doublings), or pulse labeled for a specific period of time vhen the cul
ture had reached an optical density of 0.24.

Growth was terminated by

pouring the cells over ice and removing the label by centrifugation at
10,000 rpn.
Extraction of phospholipids.
Labeled cells were extracted by a modified Bligh and Dyer procedure
(11).

Cells from 10 ml samples were collected by centrifugation, resus

pended in 0.8 ml of 0.3% NaCl and transferred to a screw-capped test
tube.

Three ml of chloroform/ethanol (1:2) were added to this screw^

capped tube and the single phase system was centrifuged using a clinical
bench top centrifuge in order to pellet the particulate matter.

The

supematent was removed, further adjusted by the addition of 1 ml of
chloroform and 1 ml of 0.3% NaCl that resulted in a two phase system
with a chloroform/methanol/water ratio of 2:2:1.8. The chloroform phase
was removed with a capillary pipette.

A single drop of 5N HCl was then

and the upper aqueous phase was reextracted twice with 1 ml of
chloroform.

The chloroform extracts were then pooled.

Card (15) had previously noted that lysozyme treatment of cells
increcised the CL content of the lipid extract.

Consequently, the def
lipidated residue was resuspended in 0.8 ml of 50 itM Tris HCl and 5 mM
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MgCl2 containing 200yi>ig/inl lysozyme and incubated at 25 C for 30 min.
The reaction was stopped by the addition of 3 ml of chlorofornvtethanol
(2:1) and the tubes were vigorously shaken at 60 C for 10 min.

Further

shaking for 30 min at roan temperature succeeded this heating step.

A

second Bligh and Dyer extraction as described above was then performed.
The choloform phases fron both extractions were pooled and taken to
dryness.
The lipids were quantified either by chromatography in two dimensicxis
on Whatman SG 81 papers or by déacylation by methanolysis and separation
of the phosphate esters.

The following solvent systems were used for

chromatography on SG 81 papers:

chlorofoiii\/methanol/2,6-dimethyl-4-hep-

tanone/acetic acid/water in the ratio 35:10:50:25:4 in the first direction
and chlorofomv/methanol/2,6-dimethyl-4-heptanone/pyridine/0.5 M NH^Cl
pH 9.8 in the ratio 60:30:45:70:12 in the second direction.
line hydrolysis was performed as described by White (128).

Mild alka
The lipid

extract was suspended in 0.5 ml of chloroform and an equal volume of
0.2 M KOH in methanol was added.

After incubatdon for two hours at 4 C,

the solution was neutralised by repeated passage over Bio-rex 70 beads
that had been prewashed with 2N HCl.

At approximately pH 7, one ml of

chloroform and one ml of 0.3% N ^ l were added and the solution was then
subsequently vortexed for two minuts.

The aqueous phase was removed

and the lower organic phase was reextracted twice more with 0.5 ml of
water.

The aqueous extracts were pooled and taken to dryness.

Separation

of the ftesphate esters was by two dimensional chronatography on acid
washed Whatman #1 papers.

These were developed in the first dimension

ty butanol/acetic acid/vater in the ratdo of 5:3:1, and in the second
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Phenol/0.1 N NH^OH (100:38 w/v).
Autoradiography using Kodak XAR-5 film or the procedure of Vaskovsky
and Kbtetsky (124) revealed the specific loci of each lipid or lipid
derivative.

The spots were then either cut out and counted in a Beckman
3 32
LS-750G programed for dual label H- P counting using Aquasol 2 (New
England Nuclear Corp) as scintillation fluor, or in the case of certain
SG 81 separations, the phos#iolipids were eluted fron the papers and
then subjected to déacylation and rechromatographed as the phosphate
esters.
Preparation of washed manbranes.
Membranes were prepared by the procedure as detailed by Sone et al.
(112).

The cells were grown in 200 ml of TYE medium to an optical den

sity of 0.24, at vhich time they were harvested on ice and centrifuged
for 30 min at 2500 rpn.

The cells were then twice washed with 20 ml of

0.15 M NaCl-50 mM Tris HCl (pH 7.8) -10 mM MgCl2. The washed cells were
then treated with lysozyme (150yug/ml in the above buffer) for 20 min,
after vhich time they were centrifuged at 10,000 rpm for 10 min.

The

pellet was then resuspended in 20 ml of 50 mM Tris HCl (pH 7.8), to vhich
vas added 0.25 ml of DNase I (Sigma) (2 roq/ml in 50 mM Tris HCl (pH 7.8)
-10 mM MgCl2)• This was then incubated for 10 min at 25 C.

The bright

red membrane pellet was obtained by centrifugation at 10,000 rpm for 30
min.

This was then washed once with 20 ml of 0.2 M NaCl-50 mM Tris HCl

(pdl 7.8)-10 mM MgCl2/ subsequently thrice washed with 50 mM Tris HCl
(pH 7.8)-10 mM MgCl2* Protein concentration was detennined by the method
of Lowery et al. (68), using bovine serum albumin as the standard.

An

average amount of membrane protein obtained frcm a 200 ml culture was in
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the order of 2 mg.
Extraction procedure for isolating bactoprenol intermediates.
The method used was that described by Ward (125) for snail scale
extractions fron prepared membranes.

All glassware was silanised and

all solutions were kept at 4 C due to the unstable nature of bactoprenol.
Twd milligrams of

labeled washed membranes were suspended in 1 ml

of distilled water, to which was added an equal volume of butanol/6 M
pyridinium acetate pH 4.2 (2:1 v/v). The system was separated into tvro
phases and the upper butanol layer was removed by capillary pipette.
The aqueous phase was reextracted two more times with 0.5 ml of watersaturated butanol.

The butanol extracts were combined and taken to

dryness.
Further purification of this extracted lipid fraction was achieved
subjecting the lipid extract to mild alkaline methanolysis as pre
viously described.

The material that remained soluble in the organic

phase was chromatographed on Whatman LPH-K plates using 2,6-dimethyl-4heptanone/acetic acid/water in the ratio 8:5:1 as the solvent.

Auto

radiography revealed the presence of the bactoprenol intermediates.
Cardiolipin synthetase assay.
Cardiolipin synthetase was assayed by the following protocol:
incubation mixture contained 40^1 of

the
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P labeled manbrane, 100y^l of

freshly prepared manbrane, ISOyMl of 0.2 M acetate buffer (pH 5.6) con
taining 10 mM HTEA, and OOy^l aliquots of the aqueous antibiotic sol
utions to give a final total volime of 0.4 ml.
for 5 min at 60 C.

This was then incubated

The reaction was terminated by the addition of 1.5

ml of chloroforn0nethanol/l N HCl (1:2:0.03).

The controls were incu-
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bated at 0 C and 60 C without the presence of the specific antibiotics.
The phospholipids were isolated frcm this assay mixture hy adding 1 ml
of 0.3% NaCl and 1 ml of chloroform.
the chlorofoim layer was removed.

A two phase syston resulted and

The aqueous phase was reextracted

two more times with 1 ml of chloroform.

The chloroform extracts were

pooled, taken to dryness, and chromatographed on SG 81 papers.
Phospholipase D assay.
Authentic phosphatidic acid was obtained frcm either PG or PE by
the method of Yang (130).

PG and PE were eluted from SG 81 papers and

the samples were taken to dryness.

They were then resuspended in water

by the means of ultrasonification and in this micellar form they were
used as substrates for the reaction.

The assay mixture was as follows:

SOyUl of the resuspended lipid, 200y*l of 0.2 M acetate buffer (pH 5.6),
lOOyiAl of the 0.4 M CaCl2/ and lO^wl phospholipase D (10 mg/ml) (Sigma).
The volume was adjusted to 0.4 ml with the buffer, to Wiich 0.5 ml of
diethyl ether was overlaid. The mixture was incubated overnight on a
wrist action shaker.

The ether was then evaporated and 0.5 ml of chloro

form and 1 ml of methanol were added to give a single phase syston.

The

solution was adjusted to a chloroforrn/methanol/water ratio of 2:2:1.8
and the resulting chloroform phase was ramoved.

The aqueous phase was

reextracted two more times with 1 ml of chloroform.

All the chloroform

extracts were pooled, taken to dryness and chrcmatographed on SG 81 papers.
Phosphorus assays.
Total inorganic phosphorus was determined by the ashing procedure
described by Ames (1).

The phos^iorus content from SG 81 papers was ob

tained by dissolving the paper in 1 ml of 70% perchloric acid.

This
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was then digested for four hours at 160 C.

After cooling, 5 ml of deion

ised water were added, followed by 0.5 ml of 2.5% ammonium mol^bdate
and 0.5 ml of Fiske-Subba Row reagent in that order.

The tubes were

heated for 7h minutes at 95 C, centrifuged to remove the insoluble
silica acid and read at 820 nm in a Coleman Junior II spectrophotcmeter.
Phosphorus was determined by oonpariscn vâth known standards.

RESULTS
The effect of various inhibitors of cell wall metabolism on phospholipid
conposition.
The major phospholipids of B. stearothennophilus are PG, PE, and CL
which constitute about 45, 35, and 20% respectively, of the total lipid
fraction of exponentially growing cells at 60 C (16).

As shown in

Table I, exposing exponentially cells to lO^g/ml of bacitracin, vanco
mycin, and ristocetin all caused an elevation of CL frcm 20% to approx
imately 45%, with a corresponding decrease in the amout of PG present.
In contrast, the phospholipid composition of cells incubated in the
presence of penicillin and D-cycloserine were similar to control cultures
where no antibiotic vas present. The effect of antibiotic concentration
on the amount of CL synthesis is shown in Fig, 3.

Increasing the con

centration of bacitracin up to 250^ g/ml (at this point the cells were
beginning to lyse) resulted in a linear increase of CL.

A comparable

effect was observed with low conentrations of both vancomycin and risto
cetin (higher concentrations tended to cause the cells to revert back
towards wild-type ^tosftolipid composition). Penicillin and D-cycloserine
did not alter the phospholipid compositions at any concentration of the
antibiotics.
A similar e)^)eriment to that described in Fig. 3 was performed with
a mutant resistant to low concentrations of bacitracin and the results
are depicted in Fig. 4.

At low concentrations of bacitracin there

appeared to be no effect on the amount of CL synthesis:

at high con

centrations the level was similar to that found using wild-type cells.
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Table I.

Phospholipid ocmposition of B .stearothentpphiliis
in the presence of bacterial cell wall inhibitors.^
PE%

PG%

CL%

control^

38

39

23

bacitracin

34

20

46

vancomycin

31

25

43

ristocetin

34

24

42

penicillin^

35

39

25

cycloserine

34

38

28

^ The antibiotics were added to an exponentially growing culture at
59 C at a final concentration of 10y(^g/ml for 20 minutes.
^ The control was identicail in all respects except that no antibiotics
were present.
^ In this experirnent, the final concentration of penicillin was 5^g/ml
due to cell lysis.
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Fig. 3.

The effect of antibiotic concentration on the amount of
cardiolipin synthesis in wild-type cells.

A culture of B .stearothennophilus was grown at 59 C and
was continuously labeled with
of 0.24.

until an critical density

10 ml sangles were then pipetted into flasks

containing the aqueous soluticHis of the antibiotics and
the cells were further incubated for 20 min.

The reaction

was stopped by pouring the cells over ice and they were
then centrifuged at 10,000 rpn for 10 min in order to
remove the label.

The phospholipids were extracted frcm

the pellet by a modified Bligh and Dyer procedure (11).
The total lipid fraction was chrcmatographed in two
dimensions on Whatman SG 81 papers utilising the following
solvent systans : chloroform/raethanol/2,6-dimethyl-4heptanone/acetic acid/water in the ratio 35:10:50:25:4 in
the first dimension, and chloroform/methanol/2,6-dimethyl-4-heptanone/pyridine/0.5 M NH4CI pH 9.8 in the ratio
60:30:45:70:12 in the second.

Autoradiography revealed

the presence of the lipids, v ^ c h were then cut out frcm
the papers and counted in a Becknen LS-7500.
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Fig. 4.

The effect of antibiotic concentration on the amount of
cardiolipin synthesis for a mutant resistant to low levels
of bacitracin.

B. stearothennophilus was mutagenised by nitrosoguanidine
(50^g/ml) and a single colony was isolated from bacitracin
selection plates (10yug/ml). The mutant was then grown in
liquid culture in TYE medium to vAiich was added bacitracin
(10yug/ml) and 0.5% glucose under identical conditions as
described in Fig. 3.
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Turnover patterns of cells labeled with

P and exposed to bacitracin.

As shown in Fig. 5, the turnover patterns of bacitracin treated
cells and control were similar.

In both cases, PG was rapidly metabol

ised, whereas PE and CL were relatively stable vAether the cells were
chased in the presence of bacitracin or not.
The effect of bacitracin, vancomycin, and ristocetin on cardiolipin
synthetase activity.
The effect on cardiolipin synthetase activity in washed membrane
suspensions vdien assayed in the presence of the antibiotics is shown in
Table II.

As can be seen, there is little difference with the suspensions

including the antibiotics to the 60 C control.
Characterisation of the unknown X .
Throughout the course of this study we noted the presence of an as
yet unidentified lipid in the total lipid fraction (Fig. 6B). In wildtype cells this lipid accounted for less than 1% of the totcil lipid
present.

In exponentially growing cells subjected to 50yi4g/ml of baci

tracin for 5 minutes, this particular conponent increased to 5% of the
total lipid in the extract.

This lipid was recovered frcm SG 81 papers

by a conventional Bligh and Dyer extraction, and after mild alkaline
methanolysis yielded a single phosphate ester vdiich we initially thought
could be glycerol phosphate (Fig. 6C).
In order to ascertain whether the deacylated form of X originated
frcm phosphatidic acid (as suggested by the above results), we chrcma
tographed authentic PA with the unknown X on SG 81 papers. As can be
be seen in Fig. 7, the acylated forms of X and PA appear to be two dis
tinct molecules.

Further confirmation of this fact was obtained by
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Fig. 5*

The effect of bacitracin on the phospholipid turnover of
B .stearothennophilus.
A culture

continuously labeled with

density of 0.24 was reached.

32
P until an opticail

The label was removed by cen

trifugation and the cells were resuspended in TYE medium
containing bacitracin (0.8yu^g/ml). The culture was then
further incubated for 20 minutes.
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Table II.

The effect of bacterial cell wall inhibitors on the
in vitro assay of cardiolipin synthetase.^

PE%

PG%

CL%

b
control 0 C

32

46

23

control 60

29

10

61

bacitracin

25

12

63

vanconycin

26

13

61

ristocetin

29

10

61

^ The reaction was performed for 5 min with the incubation buffer con
taining the antibiotics to a final concentration of 10yAg/hl.
^ Identical assay on ice in the absence of antibiotics.
^ Identical assay at 60 C in the absence of antibiotics.
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Fig. 6.

Twd dimensional chronatographic characterisation of the
unknown X;

chronatogr^hy on SG 81 papers and chronatography

of the E^sphate ester derived fron X.

The total lipid fraction was extracted as described in Fig. 3.
Fig.SA.

two dimensional chronatography on SG 81 papers of

the toted, lipid fraction.
Fig.SB.

Two dimensional chronatography on SG 81 papers of

the total lipid fraction fron cells incubated in the presence
of bacitracin (J50ytAg/ml for 20 min) revealing the position of
of the unknown X.

The unknown X was subsequently eluted

fron the SG 81 papers and was then subjected to déacylation
by mild alkaline methanolysis.
Fig.6C.

Two dimensional chromatography of the phos#iate

ester derived frcm X using Whatman # 1 papers developed
with butanol/acetic acid/water in the ratio 5:3:1 in the
first direction and phenol/0.1 N NH^OH (100:38 w/v) in the
second direction.
Fig.6D.

Two dimensional chronatography on Whatman # 1

papers of the deacylated total lipid fraction.
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Fig.6
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Fig. 7,

T w dimensional chronatography on SG 81 papers cotparing
the unkncwn X with authentic phosphatidic acid.
Autoradiographs of two dimensional separations using SG 81
papers:
Fig.7A.

X isolated fron Fig.6B and rechronatographed.

Fig.7B.

PA obtained by the action of phospholipase D using

PG as substrate.
Fig.7C.

X and PA (obtained by enzymatic action on PE)

chronatographed together revealing two distinct molecules.
Fig. 7D.

Totcü. lipid fraction serving as control.
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œ-chronatographirig the glycerol phosphate esters of each lipid, and
likewise, autoradiography revealed the presence of two spots (data not
shown).
The effect of the addition of L-serine on the phospholipid composition
of bacitracin treated cells.
If the phosphatidyl group of the suggested phosphatidyl intermediate
can be used for PE synthesis, then the addition of L-serine might effect
the phospholipid composition.

This possibility was tested by increasing

the serine concentration in the TYE medium at a fixed concentration of
bacitracin.

The results are shown in Fig. 8. Fran these data, we conclude

that serine does not appear to have a significant effect on the phospho
lipid metabolian of cells that have been simultaneously inhibited with
bacitracin.

Nonetheless, the PE content responded with a slight, but

distinct, perturbation vhen the serine concentration was increased.
The effect due to varying the length of time that cells were in the
presence of a fixed concentration of bacitracin.
The results presented thus far relied entirely upon the extraction
procedure outlined in Materials and Methods.

However, aiploying two

relatively minor modifications designed to enhance the possibility of
isolating a bactoprenol intermediate; namely, the use of silanised glass
ware and performing the phospholipid extraction at 4 C, for all the steps
other than the lysozyme treatment and the 60 C heating step, revealed
the presence of several other unknown lipid species (Fig.9).

Exposing

the cells to 50^g/ml of bacitracin for 5 minutes caused the accumulation
of a previously unseen lipid designated A.

Performing the same experi

ment but substituting vancomycin in place of bacitracin, also caused the
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Fig. 8.

The effect of L-serine on the phospholipid coiposition of
cells treated simultaneously with a fixed concentration of
bacitracin.

The same experiment was performed as described in Fig. 3
except that bacitracin (50yug/knl) and L-serine were added
together.
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Fig. 9,

The time dependent effect of bacitracin on the phospholipid
ocnposition as revealed by W o dimensional chromatography
on SG 81 papers.
The same experiment was performed as described in Fig. 3
except that the phospholipid extraction procedure was slightly
modified by using silanised glassware and performing the
extraction at 4 C, in order to aoccmadate the isolation
of bactoprenol intermediates.

The autoradiographs shew

samples taken at 0 min, 5 min, 10 min, and 20 min, and
reveal the presence of three lipids that were not previously
isolated.

These are designated as the unknowns A, B, and C.
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accmtulation of this particular lipid (data not shown). Further inspec
tion of Fig. 9 showed that the unknown lipids B and C (tentatively ident
ified as lyso-CL (Fig.lOD) and lyso-PE (Fig.KX:) respectively), decreased
with respect to time after an initial transient increase.
Characterisation of the unknown lipid A.
The accumulated lipid (unknown A) was eluted from SG 81 papers by a
conventional Bligh and Dyer procedure.

After a brief period of acid

hydrolysis (2 N H21 for 5 min at 100 C) and yet another Bligh and Dyer
purification, the lipid that was remaining in the organic phase was rechronatographed for a second time on SG 81 papers.

A molecule with very

similar migratory characteristics as demonstrated by the unknown X (Fig.TB)
resulted.

This acid hydrolysis product was recovered from this second

SG 81 separation, subjected to déacylation and rechrcroatographed yet
again, this time as the glycerol phosphate ester as shown in Fig.lOB.
This phosphate ester c^peared to correspond to a previously unidentified
ester described by Card (15).
Further characterisation consisted of comparing the unknown lipid
with bactoprenol intermediates isolated from prepared washed membranes.
As shown in Fig. 11, thin layer chromatography revealed the presence of
three major bands for all membrane preparations.

Intact unknown A

(isolated prior to acid hydrolysis) appeared to correspond to the second
of these major bands.

Previous evidence (117) and the exacting nature

of the extraction procedure, would clearly correlate all three bands
with bactoprenol.

If that is so, and that the unknown A does in fact

correspond to the second band, then we conclude that our accumulated
phospholipid due to bacitracin inhibition is ccmposed in part with the
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Pig. 10.

Characterisation of the unknowns A, B, and C by two dimen
sional chromatography of their phosphate esters.
The three lipids were eluted from the SG 81 chromatographs
shown in Fig. 9.

Unknown A was then subjected to mild acid

hydrolysis (2 N HGl for 5 min at 100 C) in order to remove
the end group from bactoprenol.

The acid hydrolysis product,

and the unknowns B and C were then subjected to mild alka
line methanolysis and chromatographed as described in Fig. 6.
The phosphate ester of C was tentatively identified glycerol
phosphate ethanolamine (Fig. IOC) ; the phosphate ester of B
was tentatively identified as glycerylphosphoglycerylphosphoglycerol, the jdK)sphate ester resulting from CL (Fig.lOD) ;
A still remains unknown (Fig.lOB); Fig.lOA is the toted,
lipid control.
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Fig. 11.

Thin layer chromatography of bactoprenol intermediates
isolated from prepared membranes.
P washed manbranes were prepared from 200 ml cultures by
the method detailed by Sone CH2). Bactoprenol was extracted
into butanol using butanol/6 M pyridinium acetate pH 4.2
(2:1 v/v). This total lipid extract was further purified by
mild alkaline methanolysis and the material that remained
soluble in the organic ftese was then separated on Whatman
LPH-K plates using 2,6-dimethyl-4-heptanone/acetic acid/water
in the ratio 8:5:1 as the solvent.
the presence of the bactoprenol.

Autoradiography revealed
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The time dependent effect of vanocnycin on the lipid ocrnposition of
washed membranes.
EîÇ)onentially growing cells were inhibited with SCyMg/ml of vanoomycin and samples were taken at various times thereafter.

The harvested

cells were then extracted for either phospholipid or bactoprenol.

Fig.l2A

shows that the elevation of CL occurs scmetime after 10 minutes from the
start of the inhibitory period.

This is in contrast to bacitracin v^ere

this rise occured prior to 5 minutes (Fig. 7).

Thin layer chromatogr^hy

of the bactoprenol intermediates isolated from the cells harvested at
various times during the inhibitory period is shown in Fig.l2B.

Upon

close inspection, it appeared that the first band increased with respect
to time with a corresponding decrease in the second band (our postulated
phosfholipid intermediate). This coordinated effect also appeared to
correspond with the elevation of CL.

51
Fig. 12.

The effect of time on vanoonycin treated cells as revealed
by two dimensional chrcroatography on SG 81 papers of the
total lipid fraction y and by thin layer chromatography of
bactoprenol intermediates isolated from washed membranes.
Fig.l2A demonstrates the delayed elevation of the CL content
in an analogous experiment as to the one described in Fig. 9.
Fig.l2B shows the separation of the bactoprenol intermed
iates isolated from washed membrane samples as described
in Fig. 11 that were taken at various times during the
inhibitory period.
All antibiotic concentrations were SOyAg/ml.
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DISCUSSION
The data presented in Table I and Fig. 3 show that on exposing
B.stearothennophilus to twenty minutes of antimicrobial action, that one
can readily see that bacitracin and low concentrations of vancomycin and
ristocetin all cause a sharp rise in the CL content; apparently at the
expense of PG.

The lack of this response with penicillin and D-cyclo*-

serine would suggest the possible involvement of the bactoprenol carrier
system.

A similar effect was recently documented with S.aureus (59).

The results that are sunmarised in Table II would tend to suggest that
this increase did not appear to be due to a direct effect of the anti
biotics on cardiolipin synthetase activity.

Also, it would appear from

Fig. 5 that bacitracin is not exerting an effect on phospholipid turnover,
albeit that in this experiment lew concentrations of bacitracin were
used.
Fig. 6 clearly demonstrates that an unidentified lipid (X) was seen
to accumulate on bacitracin treatment and initially we thought the phos
phate ester derived from X was possibly glycerol phosphate.

If this were

the case then this would have been consistent with Card's proposal (17)
that increased CL synthesis should result in a greater number of phos
phatidyl complexes.

However, two dimensional chromatography of the

unknown X with authentic PA clearly showed the existance of two different
molecules.

Also, we failed to demonstrate a significant increase in PE

content with a simultaneous addition of bacitracin and L-serine to an
eaqxonentially growing culture.

These two pieces of data tend to support

Dowhan's contention (31) that PG is not metabolised via a phosphatidyl
complex.

However, in light of Kito's (131) recent exchange data of PG

with PE in a serine auxotroph of E.coli, and some particularily puzzling
54
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studies on PE synthesis in Gram positive anaerobic organisms (19, 108,
109) would serve to ranind us that further clarification of this point
is needed.
The hope of possibly isolating a bactoprenol intemediate led us to
slightly modify the #K)spholipid extraction procedure.

The detection of

three additional lipids using this modification (Fig. 9) was particularily
encouraging.

Fran a cursory visual inspection the unknown designated A

appeared to bear sane apparent differences frcm the other well-character
ised phospholipids present.

(This particular unknown also accumulated

in the corresponding experiment using vanoanycin-data not shown). Subt
sequent characterisation of A showed that mild acid hydrolysis (to release
any end group from bactoprenol) yielded a product that was soluble in
chloroform and that chronatographed as a single spot.

This appeared to

correspond to the position of the unknown X using SG 81 papers as shown
in Fig.TB.

The deacylated end group (Fig.10) turned out to be yet another

glcerol phosphate ester when compared to deacylated X.

With this in mind,

the observation of the chromatographic properties of the end group and the
unknown X would appear to suggest that though they have been shewn to be
different molecules they may be chsnically related.
Finally, attention was focused on the isolation from washed msnbrane
preparations of the bactoprenol intermediates thanselves.

It was hoped

that if bactoprenol was involved with phospholipid metabolism then changes
in the phospholipid catçosition caused by the presence of the antibiotics
would be reflected at the bactoprenol level.

As Fig. 11 shows, the extract

from each nWbrane preparation appeared to consist of three major bands •
Previous evidence (117) documents a single major band identified as bacto-
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prenol-PP, however, a second analler, unidentified band was also detected.
Chronatogr^hing isolated intact unknown A (i.e. prior to acid hydrolysis)
on thin layer plates shewed that this canpound migrated with the second
of these major bands.

Vte believe that this is particularily strong evi

dence for the involvanent of bactoprenol in phospholipid netabolism.
Further suj^rt of this contention is found in the results depicted in
Fig. 12.

In this experiment we relied upon the fact that vancaitycin did

not cause an inroediate increase in the CL content, and this was shown at
the bactoprenol level by a diminishment of the phospholipid intermediate
accanpanying the elevation of CL.

Close inspection of the bacitracin

lane in Fig. 12 shows that most of the label appeared to be present in the
first of these major bands (evidence to date would suggest that this ccmpound is bactoprenol-PP (117) ),

Not only was the diminishment of our

phospholipid intermediate reflected in the rise in CL concentration but
it also appeared to be in conjunction with an increase of bactoprenol-PP.

Fran the evidence presented thus far, it can be seen that two funda
mental questions remain with regards to the accunulated phosftolipid
product.

They are:

what is the molecular nature of this particular

jtosftolipid intermediate? and what is the role that this purported
intermediate plays with regard to phospholipid metabolism?

As yet the molecular identity of the intermediate A is unknown.

The

evidence presented in Fig. 11 would strongly implicate the presence of
bactoprenol in this intermediate, but doubt still remains as to the
identity of the end group.

Various factors would suggest that the unknown
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X and the acid hydrolysis product are derived frcm the same molecule.
This conclusion is based upon such things as the effect of modifying the
extraction procedure vhich resulted in the disappearance of X with the
appearance of the unkncwn A; the sporadic isolation of X, that could be
accounted for by it's attachment to bactoprenol; and the extreqrely similar
chromatographic behaviour exhibited by both molecules.

(In fact with

regard to this latter point, the only difference is in the deacylated
state using the solvent system butanol/acetic acid/water). The chrcmatographic properties exhibited by X and the acid hydrolysis product in
the two systems described herein, with their apparent analogous suscept
ibility to mild alkaline hydrolysis would suggest the possibility of a
phosg^lipid end group joined to bactoprenol.

However, neither of the

two molecules were found to correspond to PA (Figs. 6, 7, and 10), yet
this is by far the most plausible explanation for a bactoprenol-phospholipid complex of this nature.
phatidyl intermediate.

This would in fact correspond to a phos

In fact neither the acylated nor deacylated

products appeared to correspond to any readily identifiable lipid in
either system.
Speculation as to the possible identity of the end group invariably
leads one to consider PG turnover.

It has long been believed that the

elucidation of PG turnover would appear to solve many of the ocmplexities
we now face concerning phospholipid metabolism.

Recently, Card (17)

presented evidence that the turnover of the phosphatidyl group of PG in
B. stearothermoFhilus resulted in the label being incorporated in lipo- teichoic acid.

Consequently, the possibility could in fact exist that

the accumulated unknown gAospholipid intermediate may be involved in
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lipoteichoic acid synthesis.

With regard to this possibility, an inter

esting property of both X and the acid hydrolysis product in the deacylated
form is that the bulk of the label applied to the papers in Figs.6C and
lOB remained at the origin.

This could possibily indicate the presence

of a chanically unfavorable group or the presence of a polymer of some
nature that remains at the origin due to seme possible physicad constraints.
Turning our attention now to the possible role that our proposed
bactoprenol phospholipid intermediate could play in phospholipid metabolisn
we find that several questions deserve further consideration.
Initially, our thoughts on the possible inhibitory effects of baci
tracin were that an analogous situation to cell wall biosynthesis was
occuring within phospholipid metabolian, namely, that bactoprenol-P would
be acting as the possible acc^>tor for the phosphatidyl complex that Card
proposed.

However, the data from Fig. 3 clearly show that upon increasing

the bacitracin concentration there is a correspcxiding incresise in CL con
tent.

It has been determined that increasing the amount of bacitracin

would increase the level of bactoprenol-PP and not bactoprenol-P, so con
sequently, the possibility now arises in that bactoprenol-PP may itself
stimulate CL synthesis by possibly acting as the initial acceptor in order
to form the intermediary ccnç>lex.

One problem with this hypothesis is

that neither vancomycin nor ristocetin has ever been associated with the
accumulation of bactoprenol-PP as a consequence of their inhibitory action
(35).

However, the results in Fig. 12 would in fact appear to support this

line of reasoning.

Here it appears that the phospholipid intermediate

decreases with respect to time with an elevation of CL that also corres
ponded to an increase in bactoprenol-PP.
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A possible explanation to account for this anonalous behaviour with
the vanccmycin treatment could be as follows.

Inihibition of the

translocase step, v M c h results in the accumulation of the intennediate
bactoprenol-PP-disaccharide-pentapeptide in cell wall biosynthesis, osten
sibly removes bactoprenol from the system.

Consequently, the cell in

trying to provide bactoprenol-P (apparently the crucial acceptor in the
bactoprenol lipid carrier cycle) breaks down the phospholipid intermediate
and as a result of this causes an elevation of CL and the formation of
bactoprenol-PP.
to bactoprenol-P.

The latter would then be subsequently dephosphorylated
This explanation would not account for bacitracin's

almost identical effect:

bacitracin treated cells have an inoperable

phosphatase enzyme and would be unable to produce the desired bactoprenol-P.
A further question that arises is at Wiat particular stage does
bactoprenol enter into ^tospholipid metabolism?
icular question is also unknown.

The answer to this partr

Without knowing the identity of the end

group nor the form of the initial acceptor make speculation on bactoprenol
entry in phospholipid metabolism engaging but as yet unfortunately fruit
less.

Possible approaches as to solving this particular impasse and the

one regarding the identity of the end group could be the use of dual
label studies with the detemination of the ^^P/^H ratio in the acid
hydrolysis product; in vitro assays of cardiolipin synthetase in \diich
the incubation buffer is siiçjplonented with either the unknown A or bacto
prenol-PP and deteimining the relative ratios of the particular products;
chanical tests to determine the exact nature of the unknown A could in
clude the use of mass spectroscopy and nuclear magnetic resonanceNonetheless, the results presented here constitute particularily

60
évidence for th6 ooupllng of cell wall synthesis and phospholipid
metabolism.

The fact that bactoprenol should appear in a phospholipid

ccnplex should not appear too surprising.

Evidence is now rapidly

accumulating (23, 34, 125, 126) that would appear to suggest that the
synthesis of teichoic acids also involves a bactoprenol intermediate.

As

teichoic acids are believed to be synthesised in part frcm phospholipid
degradation, then the occurance of a ccrnnon reaction vehicle would appear
quite plausible.

A critical aspect of this particular scenario would be

the particularily fine control that the cell could exert on macrcmolecular
synthesis.

This could be achieved by possibly regulating the flow of

bactqprenol intermediates that may be serving as acceptors for each
individual reaction sequence.

Strcminger's groL^ (38, 47, 48, 102, 129)

believes that cell wall synthesis is regulated by the dual action of a
kinase and pho^hatase that maintain the appropiate levels of bactoprenol-P.
An interesting property of this system is that the phosphatase enzyme
has an equivalent pH optimum as the one that we have determined for cardio
lipin synthetase.

These two enzymes are in sharp contrast to the rest

of the phospholipid and cell wall enzymes, vhose pH optima are all within
the range of 7-8.

Consequently, the possibility exists that both phospho

lipid and cell wall biosynthesis may well be controlled by pH gradients
across the cytoplasmic membrane.

SUMYIARY
The results obtained from this study can be sunmarised as follows:
1.

Bacitracin and low concentrations of vanocn^cin and ristocetin (all
of which have been determined to inhibit the bactoprenol lipid
carrier cycle in cell wall synthesis) all cause a marked elevation
of CL apparently at the expense of PG;

2.

This elevation does not appear to be due to the antibiotics inter
fering with phosEtolipid turnover nor by than exerting an effect on
cardiolipin synthetase activity;

3.

Depending i ^ n the extraction procedure, two different lipid inter
mediates, A and X, were seen to accumulate on antibiotic treatment.
They have been partially characterised and they appear to bear sane
similarity with each other based on their chromatographic properties.
It would appear that the unknown A is composed in part by the C55isoprenoid lipid bactoprenol (based on comparative thin layer chranatograE^y) and possibly a phospholipid moiety, the identity of which
is as yet unknown;

4.

When bactoprenol intermediates were specifically isolated from washed
manbranes, it was demonstrated that one of three major bands corres
ponded to the unknown A.

It was also shown that our accumulated

phospholipid intermediate apparently diminished with respect to time,
with a concomitant incirease in bactoprenol-PP vhen the cells were
subjected to vancomycin inhibition.

This

also coordinated with

the elevation of CL;
5.

Vfe believe that the data presented here provides evidence for the
coupling of manbrane and cell wall metabolians.
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